Paramedic PapersHome Trauma Freeze-dried plasma complements whole blood
Trauma
Freeze-dried plasma complements whole blood
The role of freeze-dried plasma in a world of whole blood: a Canadian prehospital and transport perspective
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · Added 14 May 2026
This commentary argues freeze-dried plasma complements whole blood in prehospital resuscitation, offering a scalable, shelf-stable solution for rural and remote regions with long transport times.
- Study type
- Guideline / statement
- Design
- Narrative commentary/perspective
- Participants
- Not reported
- Main finding
- Argues freeze-dried plasma is shelf-stable, pathogen-reduced and operationally feasible, complementing whole blood to extend balanced resuscitation to rural and remote Canada.
- Caveat
- Commentary without new data
- Bottom line
- Context only
Learning goal
Weigh the benefits and limitations of freeze-dried plasma alongside whole blood for balanced trauma resuscitation in remote settings.
More
- Topic: Trauma
- Daily scan: 14 May 2026
Related papers on Trauma
-
Prehospital whole blood no better than components
Multicenter randomized trial comparing prehospital type O whole blood resuscitation to standard care in trauma patients with hemorrhage.
-
Each advanced prehospital intervention adds scene time
Retrospective physician-led HEMS trauma study examining whether more advanced interventions are stretching scene times — each additional intervention increased scene time by 41%, although overall scene times stayed similar over two decades because of changing case mix.
-
Call to abandon routine spinal immobilisation
Commentary challenging continued routine spinal immobilisation in suspected spinal injury — the authors argue decades of evidence now consistently show harm without benefit, and that paramedic scope should evolve to reflect current evidence.
-
Normal CT safely rules out delayed bleed on anticoagulants
Retrospective review tested whether immediate discharge after normal CT was safe for anticoagulated head-injury patients with GCS 14-15 — no delayed intracranial haemorrhage, neurosurgical intervention, or clinically significant deterioration occurred.